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Infectious diseases have the potential to act as strong forces for genetic selection on the populations they
affect. Human immunodeﬁciency virus (HIV) is a prime candidate to impose such genetic selection
owing to the vast number of people it infects and the varying susceptibility of different human leucocyte
antigen (HLA) types to HIV disease progression. We have constructed a model of HIV infection that
differentiates between these HLA types, and have used reported estimates of the number of people
infected with HIV and the different rates of progression to acquired immunodeﬁciency syndrome
(AIDS) to provide a lower bound estimate on the length of time it would take for HIV to impose
major genetic change in humans. We ﬁnd that an HIV infection similar to that currently affecting sub-
Saharan Africa could not yet have caused more than a 3 per cent decrease in the proportion of individuals
who progress quickly to disease. Such an infection is unlikely to cause major genetic change (deﬁned as a
decrease in the proportion of quickly progressing individuals to under 50 per cent of their starting
proportion) until 400 years have passed since HIV emergence. However, in very severely affected
populations, there is a chance of observing such major genetic changes after another 50 years.
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1. INTRODUCTION
Human immunodeﬁciency virus (HIV) has had a dra-
matic effect on population age structure and life
expectancy in the developing world (Pope & Haase
2003). In 2007, there were a recorded 33 million people
infected, and this number is rising by around 2.7 million
each year (UNAIDS 2008). In the absence of anti-retro-
viral drugs, progression to acquired immunodeﬁciency
syndrome (AIDS), followed shortly by death, occurs
after an average of 11 years (Munoz et al. 1989). Genetic
variability of the host has been shown to have some effect
on the rate of HIV disease progression as well as on HIV
resistance to infection. Potential therefore exists for the
virus to exert selective pressure on its human host, just
as the host has applied selective pressure to the virus
(Heeney et al. 2006; Kawashima et al. 2009). This
paper asks how fast, and to what degree, HIV might
alter the genetic structure of the human population.
A relationship between human leucocyte antigen (HLA)
type and progression towards AIDS and death has been
shown in a number of studies. Individuals homozygous
at one or more HLA class I loci progress to AIDS faster
than those who are heterozygous (relative hazard of
progression   1.68; Carrington et al. 1999). Certain HLA
alleles, such as HLA-B*57 and HLA-B*27, are associated
with slower progression to AIDS (O’Brien et al. 2001;
Carrington & O’Brien 2003). Other HLA alleles, HLA-
B*35-Px and HLA-B*53,h a v eb e e nl i n k e dt of a s t e rH I V
disease progression and AIDS-deﬁning illness (Carrington
et al. 1999; Gao et al. 2001). The HLA-B*35-Px and
HLA-B*53 alleles have a frequency of 4.4 per cent in the
white population and 12.8 per cent in the black population
(Gaoetal.2001).TheeffectoftheHLA-B*35-Px/B*53sub-
type on progression to AIDS is signiﬁcant, and is shown in
ﬁgure 1. In a large cohort study, more than 50 per cent of
white subjects possessing the HLA-B*35-Px or HLA-B*53
allele progressed to AIDS within 6 years, while it took
over 11 years for this to occur in a similar percentage of sub-
jectsnotpossessingthealleles.Timeframesinblacksubjects
were 8 years in those with the alleles and over 17 years in
those without (Gao et al. 2001). Thus, the median time to
AIDS in individuals possessing the HLA-B*35-Px or
HLA-B*53 genotype is approximately half that in the rest
of the population. As well as this direct evidence for an
association between HLA genotype and progression to
AIDS, indirect evidence has been found in the form
of relationships between HLA supertype and viral load
(Trachtenberg et al. 2003), and between viral load and
progression to AIDS and death (Mellors et al.1 9 9 6 ).
Infectious diseases have the ability to select for and
against certain genotypes in an infected population. An
obvious example of this is the selection in parts of
Africa for the mutation responsible for sickle cell anae-
mia. This mutation is protective against infection with
Plasmodium falciparum (one of the common strains of
malaria; Allison 1954), and therefore natural selection
for it has occurred over thousands of years (Currat et al.
2002). Similarly, it has been suggested that the CCR5-
D32 deletion allele that is protective against HIV has
been previously selected for in Europe by an infectious
disease (Stephens et al. 1998; Galvani & Slatkin 2003).
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the prevalence of a disease. Assuming that other disease
parameters are equal (e.g. probability of transmission,
death rate from disease), an infectious disease with high
prevalence will exert stronger selective pressure on the
population than one with lower prevalence. A signiﬁcant
factor affecting disease prevalence is the changing behav-
iour in response to the HIV epidemic that has occurred
in many populations (Martin 1987; Nelson et al. 1996;
Stoneburner & Low-Beer 2004). Evidence of a decrease
in the number of people having sex with a non-regular part-
ner and an increase in condom use has been seen in a
number of countries in Africa (Stoneburner & Low-Beer
2004; UNAIDS 2005; Cheluget et al.2 0 0 6 ) and has con-
tributed to a decline in HIV prevalence in these countries.
The selective pressure of HIVon the genetic makeup of
the human population is currently unknown. It is likely
that prolonged exposure to HIVat high levels of infection
could cause selection for protective HLA alleles and
against alleles that speed progression towards AIDS and
death. Given the severity of the HIV epidemic, it is poss-
ible that the virus has already exerted a strong selective
pressure, and so altered the ratios of certain alleles
within the human population. In this paper, we analyse
whether, given the known growth of HIV, it is possible
that HIV has already caused signiﬁcant selection against
HLA types that enhance disease progression and death.
2. MODELLING APPROACH
To ﬁnd an estimate for how quickly HIV could remove a
certain allele from the human population, we assumed
that individuals possessing such an allele progress to
AIDS (and subsequently death) at a signiﬁcantly faster
rate than those without the allele. We set up a model of
HIV infection that includes diploid population genetics
involving such a frail allele (f ) and a normal allele (n).
We allow ‘frailty’ to be partially dominant in the main sec-
tion of the paper, and consider dominant and recessive
modes of inheritance in the electronic supplementary
material. We consider frequency changes of the frail and
normal alleles within the population owing to the disease,
although frequency-dependent selection itself does not
play a role in the model. We also develop a ‘back of an
envelope’ calculation that links prevalence levels to selec-
tive pressure and so allows simple calculations of the
expected impact of a given prevalence.
The equations we have used to model HIV transmission
dynamics (equation (4.1a,b)) are based on those
presented by Anderson et al.( 1 9 8 8 ) . We have extended
the model to include three different groups in the
population—individuals homozygous for the normal
allele, heterozygotes and individuals homozygous for the
frail allele. When modelling the dynamics of an infectious
disease in a single intermixing population, the initial rate of
increase and the eventual plateau in the number of infected
individuals are inextricably intertwined. It takes hundreds
of years to achieve a plateau level of 30 per cent disease
prevalence in the population. What we have seen with
HIV in the worst-affected populations is a rapid rise to
around 30 per cent of the population infected after several
decades, and a plateau at this level. It is not possible to
achieve such dynamics from a model of a population
with homogeneous, time-stable rates of infection prob-
ability and partner change even by introducing a frail
allele. Thus, we altered the model so that it was capable
of reﬂecting observed HIV dynamics by allowing the prob-
ability of infection and the rate of partner change to vary
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Figure 1. Kaplan Meyer curves showing the effect of the HLA-B*35-Px and HLA-B*53 alleles on survival for (a) white
(n ¼ 510) and (b) black (n ¼ 181) HIV-infected individuals. Grey line, no B*35/53; black line, B*35-Px heterozygotes.
Figure is adapted from ﬁg. 2 of Gao et al. (2001).
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changes (and thus lower rates of infection) that have been
observed in many parts of Africa, and ensure that our
model can produce dynamics that occur over the observed
time scales of HIV spread in the population.
3. PREVALENCE LEVELS
The HIVepidemic is taking a number of different courses
throughout Africa (and indeed throughout the world).
Reports from some parts of Africa show that the epidemic
is already declining in prevalence (Stoneburner & Low-
Beer 2004; UNAIDS 2005; Cheluget et al.2 0 0 6 ), while
otherreportsshowthatprevalencehascontinuedtoincrease
and recently appears to have plateaued (in some areas at
levels as high as 30 to 40 per cent; Asamoah-Odei et al.
2004). The prevalence of HIV is a key determinant of its
selective pressure. From available prevalence data, we
selected three sites to represent distinct courses the epi-
demic can take. We will discuss the effect that each of
these three prevalence ‘scenarios’ could have on the genetic
makeup of the population.
The selected prevalence scenarios are shown in
ﬁgure 2a. We label them as (i) low, (ii) high and
(iii) disappearing. ‘Low’ means an infection that rises to
infect 6 per cent of the population and plateaus at this
level. An example of such an infection is found in Jalingo,
Nigeria (WHO 2008a). ‘High’ means an infection that
rises to infect around 30 per cent of the population, and
plateaus at this level. An example of such an infection is
found in the Eastern Cape Province of South Africa
(WHO 2008b). ‘Disappearing’ means an infection that
rises quickly to infect close to 30 per cent of the popu-
lation, but then decreases after this peak. An example of
such an infection is found in Meru, Kenya (National
AIDS Control Council & National AIDS and STD
Control Programme 2007). We select parameter values
for the model that allow us to produce prevalence
curves similar to those in ﬁgure 2a. The prevalence
curves produced by the model are shown in ﬁgure 2b.
4. THE MODEL
When deﬁning the model, we use subscripts of i to denote
thedifferentgenotypeswithinthepopulation.Thesubscript
i ¼ 1 refers to the subset of the population homozygous for
the normal allele (nn), i ¼ 2 refers to the heterozygous
subset (nf )a n di ¼ 3 refers to the subset that are homozy-
gous for the frail allele (ff ). The susceptible population in
subset i is represented by Xi(t) and the infected population
by Yi(t). The total population in subset i is represented by
Ni(t), with Ni(t) ¼ Xi(t) þ Yi(t). Note that although Xi(t),
Yi(t)a n dNi(t) are functions of time, we have omitted to
explicitly state this where it simpliﬁes notation. The sub-
script of ‘tot’ indicates a sum over all values of i.S of o r
example, Ytot ¼
P3
i¼1 Yi. The terms BXi and BYi deﬁne
the children born to infected and uninfected mothers,
respectively, in group i, and are deﬁned in equations
(S1.1a–f ) in the electronic supplementary material.
The model we use is
dXi
dt
¼ nðBXi þ 1BYiÞ
|ﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ}
healthy births
  mXi |{z}
natural deaths
  bðtÞcðtÞXi
Ytot
Ntot
  
|ﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ}
new infections
ð4:1aÞ
and
dYi
dt
¼ bðtÞcðtÞXi
Ytot
Ntot
  
|ﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ}
new infections
  mYi |{z}
natural deaths
  aiYi |ﬄ{zﬄ}
infection-related deaths
;
ð4:1bÞ
where n gives the birth rate in the healthy population, m is
the rate of death from non-infection-related causes and 1
is the fraction of uninfected offspring born to infected
mothers. This means that (1 2 1) is the fraction of offspring
who acquire infection through perinatal transmission. The
ﬁrst part of the healthy births term in equation (4.1a)r e p -
resents the children born to uninfected mothers, and the
second part represents the children born to infected
mothers but who do not acquire the disease through perina-
tal transmission. We do not include the children who
acquire disease through perinatal transmission in our
model, as these children are likely to die at a young age
from disease (prior to reproductive age) and so will not con-
tribute signiﬁcantly to population dynamics. Omitting these
children from the model does not alter the results. We
assume that all children born to healthy mothers are healthy.
Within the new infections term (ﬁnal term of equation
(4.1a) and ﬁrst term of equation (4.1b)), the parameter
b(t)c(t) is a product of b(t), the probability of acquiring
HIV from one infected partner at time t,a n dc(t), the aver-
age rateofacquiringpartnersattimet.Changes inpractices
such as increased condom use will cause b(t)t od e c r e a s e
over time. Similarly, changes in the number of non-regular
sexual partners and rates of partner acquisition will cause
c(t) to decrease. We allow the combined function b(t)c(t)
to decrease over time in order to capture these behaviour
changes. The combined function b(t)c(t) starts from an
initial value, w0, and decreases to a lower value, wend,o v e r
at i m ei n t e r v a lf r o mt1 to t2, and takes the following form:
bðtÞcðtÞ¼
w0 t   t1
w0   wend
t1   t2
  
t t1 , t , t2
wend t   t2
8
> > <
> > :
ð4:2Þ
The values used for b(t)c(t) are given in the legend of
ﬁgure 2 and table S2 in the electronic supplementary
material, and are in agreement with reported estimates
of behaviour change (Stoneburner & Low-Beer 2004;
Cheluget et al. 2006); however, it is important to note
that model results are dependent only on the prevalence
of HIV predicted by the model, which we have matched
to observed HIV prevalence levels (ﬁgure 2), and do
not depend on the exact parameter values chosen.
Indeed, different parameter values that give rise to the
same prevalence levels will yield identical results (see
the electronic supplementary material).
In this model, we have assumed that random mating
occurs between infected and uninfected individuals, and
that the population has a uniform age structure. Allowing
for assortative mating or including age structure in the
population would increase the length of time required
for selection against the frail allele to occur (see the
electronic supplementary material).
Selection of HIVon humans D. Cromer et al. 1983
Proc. R. Soc. B (2010)(a) Implementing the model
The parameters used to implement the model are given in
the legend of ﬁgure 2, and in tables S1 and S2 in the
electronic supplementary material. Results of modelling a
low-prevalence infection, a high-prevalence infection and
a disappearing infection are shown in ﬁgure S1 in the elec-
tronic supplementary material. For all diploid simulations,
we have assumed that frailty is partially dominant and that
initially 10 per cent of the population is heterozygous for
the frail allele. The results of simulations with different
starting ratios of frail individuals are discussed in the elec-
tronic supplementary material. These assumptions agree
with data from Gao et al. (2001), which suggest partial
dominance and a 4 to 13 per cent prevalence of the
B*35-Px/B*53 allele. In this and all simulations, we
assume that the genetic makeup of the population is
initially in Hardy–Weinberg equilibrium. This equilibrium
determines that initially 0.3 per cent of the population is
homozygous for the frail allele. In all cases, the prevalence
of the frail allele decreases and the prevalence of the
normal allele increases in the population. This results in
a decrease in the percentage of individuals with the frail
phenotype in the population.
5. TIME UNTIL GENETIC MODIFICATION OF THE
POPULATION DURING AN HIV EPIDEMIC
To analyse the effect of the current HIV epidemic on the
genetic makeup of the population, we consider the gen-
etic changes during the high, low and disappearing
epidemics shown in ﬁgure 2. For the ﬁrst part of our
analysis, we make the same assumptions as above,
namely that frailty is partially dominant, that 10 per
cent of the population is initially heterozygous for the
frail allele and 0.3 per cent is initially homozygous for
the allele. This implies an initial prevalence of the frail
allele of 5.3 per cent. We allow frail individuals to proceed
to death in 5.5 years, half the time for normal individuals,
who die 11 years after becoming infected. Those who are
homozygous for the frail allele die even faster, in 3 years.
These timings are inferred from ﬁgure 1 and Gao et al.
(2001). Figure 3a shows the relative proportion of the
frail allele remaining in the population compared with
its starting proportion predicted by our model for each
of the three prevalence scenarios given in ﬁgure 2.
For a low-prevalence infection, the frequency of the frail
allele is predicted to remain above 90 per cent of its starting
proportion until at least 2080 and only to decrease to 62
per cent of its starting proportion after 500 years. For a
high-prevalence infection, it would take 110 years for the
frail allele to drop below 50 per cent of its initial proportion
and 260 years for it to drop below 20 per cent of its initial
ratio. It should be noted that for this to occur, the infection
prevalence is required to remain at 30 per cent for the next
few hundred years. If the prevalence of HIV were to
decline, these estimates would increase. We would expect
the frail allele frequency in the population to be above 72
per cent of its starting proportion for the next 20 years,
indicating that selection is still quite slow. During an infec-
tion that peaks and disappears (green lines in ﬁgure 3a), a
maximum decrease in the proportion of the frail allele is
attained following the peak of infection when it drops to
86 per cent of its starting value. The long-term proportion
of the frail allele is 91 per cent of that before the epidemic.
We can calculate the expected decrease in the percentage
of the frail alleles present over the 30 years that HIV has
affected population dynamics. We ﬁnd that for a low preva-
lence infection, the proportion of frail alleles has decreased
by just 4 per cent to 96 per cent of its initial proportion.
For a high-prevalence infection, it has decreased to 83 per
cent of its starting proportion; and for a disappearing
infection to 87 per cent of its starting proportion.
We observe that an infection that peaks and disappears
does not dramatically alter allele and phenotype frequencies
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Figure 2. Examples of different prevalence patterns taken by HIV. (a) Data from three different sites: blue line, low (Jalingo,
Nigeria); red line, high (Eastern Cape Province, South Africa); green line, disappearing (Meru, Kenya). (b) Model prevalence
outputs from three parameter sets for partial dominance with 10 per cent of the population initially heterozygous for the frail
allele: blue line, low simulated; red line, high simulated; green line, disappearing simulated. Parameters used are n ¼ 0.04, m ¼
0.02, a1 ¼ 0.071, a2 ¼ 0.162, a3 ¼ 0.313, 1 ¼ 0.7, y0 ¼ 0.1%. Parameters for equation (4.2) vary for the different prevalence
scenarios, and are: low prevalence, w0 ¼ 0.4, wend ¼ 0.117, t2 ¼ 10, t2 ¼ 20; high prevalence, w0 ¼ 0.4, wend ¼ 0.124, t2 ¼ 19,
t2 ¼ 25; disappearing prevalence, w0 ¼ 0.55, wend ¼ 0.02, t2 ¼ 10, t2 ¼ 20.
1984 D. Cromer et al. Selection of HIVon humans
Proc. R. Soc. B (2010)(green line in ﬁgure 3a), as it does not impose
lasting selection on the population. Therefore, for the
remainder of our analysis, we focus on the low- and high-
prevalence infection scenarios, as it is these scenarios that
have the potential to result in sustained genetic selection.
6. A SIMPLIFIED MODEL TO PROVIDE
A LOWER BOUND ESTIMATE
We next attempt to provide a lower bound estimate on the
time it would take for HIV to impose genetic selection on
the human population owing to selection against a frail
genotype. Our aim in providing such a lower bound esti-
mate is to provide a generalized result that is not
dependent on as many parameters and removes some of
the assumptions about the disease, while still being able
to provide insight into the maximum speed at which
HIV is capable of imposing genetic selection.
We wish to ﬁnd a lower bound estimate on how quickly
HIV could remove some genes from the human popu-
lation, so we assume a very dramatic impact on a small
subset. We make three additional simplifying assumptions
in this model. These are as follows:
— Within the frail subset, there is 100 per cent failure to
reproduce healthy children, as infected individuals
either pass on the disease through perinatal trans-
mission or die prior to reproduction.
— The ‘gene’ for frailty or normality is passed on
directly from mother to child and the father’s geno-
type has no effect.
— Only uninfected individuals are considered. Infected
individuals die at a signiﬁcantly faster rate than unin-
fected individuals, and therefore are removed from
the population relatively quickly after becoming
infected. They thus have a less signiﬁcant effect on
the population structure, and removing them from
the analysis should not greatly alter the results.
These are all assumptions that will tend to speed up the
rate of genetic change, while greatly simplifying the
model so that analytical results are possible. The simpli-
ﬁed model will therefore provide a conservative estimate
of the time taken for genetic change to occur.
(a) Setting up the simpliﬁed model
In this section, we use the subscripts of j to denote the
different phenotypes within the population. The subscript
j ¼ 1 refers to the normal phenotype and the subscript
j ¼ 2 refers to the frail phenotype. As previously, the sus-
ceptible population in subset j is represented by Xj(t)a n d
the infected population by Yj(t).
The model we use is
dX1
dt
¼ nX1 þ n1Y1 |ﬄﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄﬄ}
healthy births
  mX1 |ﬄ{zﬄ}
natural deaths
  bðtÞcðtÞgðtÞX1 |ﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ}
new infections
ð6:1aÞ
and
dX2
dt
¼ nX2 |{z}
healthy births
  mX2 |ﬄ{zﬄ}
natural deaths
  bðtÞcðtÞgðtÞX2 |ﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ}
new infections
; ð6:1bÞ
where n, m, b(t), c(t)a n d1 are deﬁned as in §5a n dg(t)i sa
function representing the prevalence of HIV in the entire
population at time t,s u c ht h a tgðtÞ¼YtotðtÞ=NtotðtÞ.
(b) Solutions to the simpliﬁed model
To solve equation (6.1a), we observe that Y1 ¼ Y1/X1 X1  
Ytot/Xtot X1 as the normal subset of the population is much
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Figure 3. Relative decreases in frequencies of the frail allele and phenotype in the years following an HIVepidemic. Proportions
are shown relative to the initial proportion of frail alleles within the population. (a) Relative frequency decreases of the frail allele
obtained when solving equation (4.1a,b) in the presence of a low-prevalence (blue line), high-prevalence (red line) and disappear-
ing (green line) infection. We have assumed that inheritance of the frail allele is partially dominant and that initially 10 per cent of
the population is heterozygous for the frail allele. Parameters are as for ﬁgure 2b.( b) Relative frequency decreases in the proportion
of frail susceptible individuals estimated using equation (6.5). n ¼ 0.04, 1 ¼ 0.7 and g(t) taken from ﬁgure 2a. Results are shown
for a simpliﬁed low-prevalence (blue line), simpliﬁed high-prevalence (red line) and simpliﬁed disappearing (green line) infection.
Selection of HIVon humans D. Cromer et al. 1985
Proc. R. Soc. B (2010)larger than the frail subset. Therefore, we can write
Y1  ðYtot=NtotÞ=ððNtot  YtotÞ=NtotÞX1 ¼ðgðtÞ=ð1 gðtÞÞX1
and we have
dX1
dt
¼ð n   mÞþn1
gðtÞ
1   gðtÞ
  bðtÞcðtÞgðtÞ
  
X1 ð6:2aÞ
and
dX2
dt
¼ð n   mÞ bðtÞcðtÞgðtÞ ½  X2: ð6:2bÞ
We can then ﬁnd solutions to equations (6.2a,b)a s
X1ðtÞ¼X1ð0Þe
ðn mÞt 
Ð t
0 bðsÞcðsÞgðsÞdsþn1
Ð t
0 gðsÞ=ð1 gðsÞÞds ð6:3aÞ
and
X2ðtÞ¼X2ð0Þe
ðn mÞt 
Ð t
0 bðsÞcðsÞgðsÞds: ð6:3bÞ
Equations (6.3a,b) can be combined to give
log
X2ðtÞ
X1ðtÞ
  
¼ log
X2ð0Þ
X1ð0Þ
  
  n1
ðt
0
gðsÞ
1   gðsÞ
ds: ð6:4Þ
We let rðtÞ¼ð X2ðtÞ=X1ðtÞÞ ðX2ð0Þ=X1ð0ÞÞ = be the
change in the ratio of frail to normal susceptible individ-
uals compared with the starting ratio (i.e. the relative
change in the proportion of frail susceptible individuals),
and we have
rðtÞ¼e
 n1
Ð t
0 gðsÞ=ð1 gðsÞÞds: ð6:5Þ
This allows us to determine a conservative estimate for
the relative decrease in the proportion of frail susceptible
individuals using only known prevalence levels, the birth
rate and the rate of perinatal transmission. Analytical
expressions for r(t) and the related function T(r), the
time taken for the ratio of frail to normal susceptible indi-
viduals to drop below r per cent of its starting ratio, can
be determined when the prevalence function, g(t), takes
certain simple forms. Expressions for ‘broken-stick’ and
triangular functions of g(t) are given in the electronic
supplementary material.
A further simpliﬁcation can be obtained by assuming
that the percentage ofinfected individuals in the population
has been constant since HIV was ﬁrst detected (i.e. HIV
suddenly appeared and infected g per cent of the
population). Then, we have g(t) ¼ g, and equation (6.4)
takes the form
log
X2ðtÞ
X1ðtÞ
  
¼ log
X2ð0Þ
X1ð0Þ
  
  n1
g
1   g
t: ð6:6Þ
The selection coefﬁcient, s, against the frail subset is
given by
s ¼
n1g
ð1   gÞ
: ð6:7Þ
This is also the difference between the Malthusian par-
ameters of the frail and normal phenotypes that is
obtained when substituting g(t) ¼ g into equations
(6.3a,b), and is therefore the selection coefﬁcient that is
obtained using standard population genetics results
(Dykhuizen & Hartl 1980; Hartl & Clark 1997). We
can use the selection coefﬁcient to determine an
expression for T(r), the time taken for the ratio of frail
to normal susceptible individuals to drop below r per
cent of its starting ratio, as
TðrÞ¼
 logðrÞ
s
¼
 logðrÞð1   gÞ
n1g
: ð6:8Þ
For an infection with 6 per cent prevalence (low) we
have s ¼ 0.00179, and for a high prevalence infection
(30 per cent prevalence) we have s ¼ 0.012.
(c) Time until genetic modiﬁcation of the
population using the simpliﬁed model
In ﬁgure 3b, we show graphs of r(t), the relative decrease
in the proportion of frail susceptible individuals, calcu-
lated using equation (6.5) for each of the three
prevalence scenarios of ﬁgure 2a. We have allowed g(t)
to be determined by interpolating each of the prevalence
curves. For times beyond those shown in ﬁgure 2a, g(t)i s
given a constant value for the low- and high-prevalence
scenarios, and is extended to a zero-prevalence infection
over 4 years for the disappearing infection. The resulting
curves of r(t) shown in ﬁgure 3b are signiﬁcantly steeper
than similarly coloured curves in ﬁgure 3a. This conﬁrms
that the solution to our simpliﬁed model is indeed a con-
servative estimate of the relative decrease in the
proportion of frail individuals in the population.
These results show that even a conservative estimate of
the time required for genetic selection suggests that it
would take hundreds of years to signiﬁcantly alter the ratio
of frail to normal individuals in the susceptible population.
During a low-prevalence infection, it would take over 400
years for the proportion of frails in the susceptible popu-
lation to decline below 50 per cent of its starting value,
and over 900 years for it to decrease below 20 per cent.
Even during a high-prevalence infection, it would take
over 78 years for the proportion of frails in the susceptible
population to decrease to below 50 per cent of its starting
value, and 158 years for it drop below 20 per cent. These
times are signiﬁcantly greater than the 30 years for which
HIVhashadanobservableimpactonpopulationdynamics.
We can also calculate the maximum decrease in the ratio
of frail to normal individuals in the susceptible population
over the 30 years that HIV has affected population
dynamics. We ﬁnd that for a low-prevalence infection,
this ratio could not have declined below 97 per cent of its
starting value, and for a high-prevalence infection it could
not have declined below 87 per cent of its initial value.
We can use equation (6.8) to calculate the time it
would take for the prevalence of the frail allele in the
population to decrease below r per cent of its starting
proportion using the selection coefﬁcients calculated ear-
lier. We ﬁnd that for a low-prevalence infection (s ¼
0.00179) it would take 387 years for the frail allele to
decrease below 50 per cent of its starting ratio, and 899
years for the ratio to decrease below 20 per cent.
During a high-prevalence infection (s ¼ 0.012), it would
take 58 years for a 50 per cent decrease and 134 years
for the ratio to decrease below 20 per cent.
7. CONCLUSION
Our analysis suggests that although HIV has had an enor-
mous impact on the sub-Saharan African population, it
could not yet have wiped out an entire subset of this
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death. Even an extremely conservative estimate in the
most severely affected areas suggests that it would take a
minimum of another 50 years (more than double the
length of time for which HIV has been at a detectable
level) for HIV to lower the ratio of frail individuals in
the susceptible population to below 50 per cent of its
ratio prior to the introduction of HIV. Our less conserva-
tive estimates suggest that it is actually likely to take more
than 100 years for this to occur.
It is important to note that within our simpliﬁed
model, we have made an extremely conservative assump-
tion, namely that there is 100 per cent failure to
reproduce in the frail group. This allows us to provide a
lower bound estimate on the time taken for the frail
subset of the population to decline. Relaxing this assump-
tion increases numbers in the frail subset of the
population and so increases the estimated time for the
frail subset to disappear from the population. Even this
very conservative estimate of a severe disease shows that
HIV could not have already eliminated a frail subset
from the population.
During this analysis, we have assumed that HIV has
only had an observable impact on population dynamics
since its discovery in 1981. Although HIV was around
prior to this time, its prevalence was extremely low and
so we have ignored this early phase. In actual fact, assum-
ing that HIV has been around for longer than 25–30
years would have increased our estimates for the time
taken for the percentage of frail individuals to decrease.
In this analysis, we have considered different long-term
outcomes by analysing the effects of a low-prevalence, a
high-prevalence and a disappearing-prevalence infection
would have on the time required for genetic selection.
However, it is probable, and indeed hopeful, that
improvements in HIV drugs, a better distribution of exist-
ing drugs and the development of a prophylactic vaccine
could affect our long-term predictions. The effect of
each of these interventions would be to slow down the
speed of genetic selection by decreasing infectivity and
lowering transmission. Therefore, once again, the results
presented here are estimates of the minimum time
required to see signiﬁcant changes in allele frequencies
owing to selection imposed by HIV.
Resistance to HIV has been associated with certain gen-
otypes that make up a small subset of the population.
Individuals with a CCR5-D32 mutation on the CCR5
chemokine receptor are highly resistant to HIV infection
(Dean et al.1 9 9 6 ; Huang et al.1 9 9 6 ). In addition, an
HLA supertype, A2/6802, is associated with resistance to
HIV infection through both sexual and perinatal trans-
mission (MacDonald et al. 2000, 2001). It has been
more difﬁcult to determine genes associated with increased
susceptibility to HIV. Although some studies have
suggested HLA types that may confer increased suscepti-
bility (Cruse et al.1 9 9 1 ; Fabio et al.1 9 9 2 ; Achord et al.
1996; Rohowsky-Kochan et al.1 9 9 8 ; Habegger de
Sorrentino et al.2 0 0 0 ), a general agreement has not been
reached (Carrington & O’Brien 2003). Therefore, this
work has not focused on the potential removal of a geno-
type from the population owing to increased susceptibility.
An issue with this work could arise if the frail subset of
the population is also more susceptible to contracting
HIV infection or if they have a signiﬁcantly different
probability of perinatal transmission. In general, however,
neither the HLA types that have been associated with
increased HIV susceptibility nor those that have been
associated with a different probability of perinatal trans-
mission are the same as those that have been associated
with faster progression to AIDS (Rohowsky-Kochan
et al. 1998; MacDonald et al. 2001; Carrington &
O’Brien 2003; Farquhar & John-Stewart 2003). This
means that there should be no confounding effects on
our analysis from increased susceptibility or different
rates of perinatal transmission. It has, however, been
suggested that the HLA-B*53 allele, which causes faster
progression to AIDS (Gao et al. 2001), may be associated
with resistance to HIV (Rohowsky-Kochan et al. 1998).
Nevertheless, if this is the case, it does not alter our con-
clusions as it would mean that the true time for the ratio
of frail individuals to decrease below a percentage of its
starting value is greater than that presented in this
paper, and so the estimates presented here are once
again conservative.
The results of our model are in agreement with those
presented by Schliekelman et al. (2001), who suggested
that a constant high-prevalence infection could cause a
50 per cent relative decrease in an AIDS-accelerating
haplotype over a period of 100 years. This is similar to
our conservative estimate of the time required for a 50
per cent relative decrease in the frail phenotype. A
major advantage of our work over this previous result is
that our model allows one to calculate the selection
pressure of an epidemic for which the prevalence changes
over time either as a result of behaviour changes or as a
result of other factors.
In this model, we have assumed that male population
dynamics track female population dynamics. Although
there are certainly differences between male and female
behaviour, this simpliﬁcation has routinely been used in
models of HIV dynamics (WHO & UNAIDS 2002;
Brown et al. 2006). In order to model the male and
female sections of the population separately, one would
require estimates of gender-speciﬁc transmission rates
and the different rates of partner formation between the
sexes (Williams et al. 2006; Hallett et al. 2007). Such a
model may also need to divide the population into differ-
ent risk groups to capture the full range of gender-speciﬁc
behaviours (Hallett et al. 2007; Nagelkerke et al. 2007).
Understanding how the inclusion of these factors affects
the rate of genetic selection owing to HIV would present
an interesting avenue for future research.
Our analyses have not considered coevolution of host
and virus. Recent data demonstrate clearly that HIV is
adapting to human immune responses at the population
level (Kawashima et al. 2009). However, in these ﬁndings,
the people exerting the strongest (detected) selective
pressures are members of a small subset that does particu-
larly well. In this work, we consider the rate of
disappearance of a different small subset that does par-
ticularly badly and is not a major force exerting selective
pressure on the virus. In addition, any selection that is
occurring in the normal or resistant section of the popu-
lation is unlikely to affect the rate of disappearance of a
frail subset. For the purposes of these calculations, it
was therefore not necessary to include evolutionary
change in HIV, or to consider selection effects in the
normal population.
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contained in our model, we have been able to conclude
that a frail subset of the population, which progresses to
AIDS and death more quickly than the rest of the popu-
lation, could not, however, have decreased dramatically.
Even in the face of an extremely severe and continuing
HIV epidemic, it would take well over double the length
of time for which HIV has been around for this frail
subset to decrease to below half of its initial ratio in the
population. This is an extremely conservative estimate,
and the true length of time it would take for this subset
of the population to decline is probably more than four
times the duration of the current HIV epidemic.
We would like to thank Mary Carrington and George Nelson
for their assistance in producing ﬁgure 1.
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